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Abstract 
Background 
There has been a policy shift away from hospital to community in the services of all 
those with psychiatric disorders, including those with intellectual disability, in the last 
fifty years. This has been accompanied recently by the growth of assertive outreach 
services, but these have not been evaluated in intellectual disability services. 
Method 
In a randomised controlled trial we compared assertive outreach with ‘standard’ 
community care, using global assessment of function (GAF) as the primary outcome 
measure, and burden and quality of life as secondary measures.  
Results 
We recruited thirty patients, considerably less than expected; no significant 
differences were found between the primary and secondary outcomes in the two 
groups. The differences were so small that a Type II error was unlikely. 
Conclusions 
Reasons for this lack of specific efficacy of the assertive approach are discussed and it 
is suggested that there is a blurring of the differences between standard and assertive 
approaches in practice.  
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Introduction 
It is well recognised that the shift from hospital to community services has been at 
least as dramatic in ID services as in general psychiatry, with key changes to service 
delivery and the comprehensive development of CTLDs (Community Learning 
Disability Teams), which provide services for both physical and mental health 
problems (Aspray et al. 1999). Within this model, mental health professionals 
provided specialist input for those with dual diagnosis (Alexander et al. 2002). In 
some areas specialist assertive outreach teams have also been established. This paper 
evaluates the effectiveness of such teams. 
 
In a large randomised controlled trial (the UK 700 Study) it was found that people 
with severe mental illness did not benefit preferentially from intensive case 
management compared with standard case management (Burns et al. 1999). However, 
the outcomes in the subset with borderline intelligence (nearly one in five of the total) 
were significantly superior (P<0.003 for primary outcome) in those allocated to 
intensive case management (Tyrer et al. 1999; Hassiotis et al. 2001). It was therefore 
considered appropriate to ask whether this finding extended to intellectual disability 
(ID) services in general.  
 
This led to the development of TACTILD (Trial of Assertive Community Treatment 
in Learning Disability), a research proposal designed to evaluate the effectiveness of 
community interventions using a similar randomised design. There are already a 
number of community teams that purport to work assertively in the UK which offer 
specialist input for behavioural and psychiatric difficulties, and our study was 
designed to evaluate their effectiveness.   
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Methods 
Specific hypotheses 
Three hypotheses were tested in the trial:- 
(a) that global improvement of clinical and social functioning of those with 
learning disability, dual diagnosis and/or challenging behaviour, would be 
superior in those treated by an assertive community team compared with those 
in a standard team; 
(b) that improvement in quality of life in this population would be superior in 
those treated by an assertive community team compared with the standard 
team; 
(c) that the burden of care on carers in this population would be no different in those 
treated by an assertive community team compared with the standard team. 
 
Design of study 
A simple parallel design with randomised allocation to two arms; assertive outreach 
and standard teams with baseline assessments at the point at which additional service 
input was considered for patients with a psychiatric disorder or challenging behaviour, 
and repeat assessments 12 weeks later. The trial was pragmatic in design with an 
intention-to-treat analysis of data of all randomised patients. The inclusion criteria 
included patients with mild or moderate intellectual disability who had either (i) 
serious mental health problems or (ii) challenging behaviour, or both (i) and (ii), (iii) 
were living in community homes with professional carers or in family homes with 
relatives, (iv) were aged between 18-65 years, and (v) gave consent and assent for the 
trial. Exclusion criteria included clients with an IQ more than 75, had severe learning 
disability and/or whose problems are assessed as sufficiently severe to need assertive 
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treatment and for whom the risk of randomisation would be unethical. The trial had an 
external randomisation officer based at a different site in London from either of the 
recruitment centres; randomisation was generated using a random number list.  
 
Definition of assertive community treatment  
A preliminary review of services within the areas considered for the study showed 
that ‘assertive treatment’ was interpreted differently, ranging from a full-integrated 
team working long-term with patients to visits which were additional to standard care 
at times of crisis. Consequently it was agreed that ‘assertiveness’ was best measured 
in terms of frequency and types of contact rather than by team structure, and thereby 
differed from similar trials in adult psychiatry (Tyrer et al. 1998; Creed et al, 1999). 
The “assertive” group was therefore defined as those who received more than one 
visit per week from one or more professionals and the “standard” group that received 
no more than one visit per week from any one professional in a week. This reflected 
actual practice in most teams when an assertive model was employed, and helped to 
justify distribution of resources (Oliver et al. 2002). 
 
Ethical and logistical issues 
The trial was regarded as a dramatic new venture and debate among providers and 
commissioners lasted a year before the design was finalised. Initially ten intellectual 
disability services in North London expressed interest in the study but this quickly 
reduced to six, essentially because of ethical concerns (Oliver et al 2002). The 
eventual study design received London multi-centre research ethical committee 
(MREC) approval as well as their local research ethical committee (LREC) approval. 
In order to overcome the reservations by some centres previously reported (Oliver et 
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al. 2002) it was decided that following referral to services there would be a two-week 
assessment and service users would be placed into one of three groups;  
A) Needing assertive treatment and would be unethical to randomise;  
B) Could be randomised;  
C) Failed to satisfy inclusion and exclusion criteria. 
Only Group B patients were randomised but as Group A qualified for inclusion in 
principle they are included in the CONSORT flow chart (Figure 1). 
 
Assessment measures and procedure 
After referral to specialist mental health services and a two-week clinical assessment, 
suitable patients were randomly assigned to assertive community treatment (ACT) or 
standard community treatment (SCT) in one of three centres; two within the London 
area (Brent and Harrow) and one from North Leicestershire. The following 
assessments were made at baseline:- 
(i) Multi-axial diagnosis (including level of intellectual disability, ‘serious 
mental health problems’ and ‘challenging behaviour’ were assessed at 
baseline using the DSM IV multi-axial assessment with ICD 10 codes 
(Cooray et al. 2000); 
(ii) Global assessment of function (GAF) with ‘symptomatology’ and ‘social 
function and performance’ separately assessed (Tyrer & Casey, 1993) in 
order to improve reliability of the measure, which has particular problems 
of assessment in intellectual disability (Oliver et al, 2003); 
(iii) Burden on carers using the Uplift/Burden scale (Pruchno, 1990); 
(iv) Quality of life (QOL) using the WHOQOL Bref (WHOQOL Group, 
1995). 
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Of these the psychiatrist made the diagnostic assessments and a research associate 
(PO) the other assessments. All non-diagnostic assessments were repeated after 12 
weeks by the research associate masked to knowledge of treatment.    
 
The WHOQOL-Bref is a standardised quality of life assessment tool for the general 
population, which has been applied to the intellectual disability population 
(WHOQOL Group, 1995). The uplift/burden scale was selected as it has good 
psychometric properties amongst carers of Alzheimer’s patients, who can be 
considered a similar population to carers of people with intellectual disability and 
mental health problems (Pruchno, 1990). 
  
The GAF ‘symptomatology’ and ‘social function and performance’ (Tyrer & Casey, 
1993), consists of two continuous scales ranging from 1 – 90 in which the anchor 
points were only guides, all forms of disability and symptomatology were assessed, 
and some allowances would normally be made for the intellectual level of the subject 
concerned when scoring an individual’s function. The quality of life assessment was 
completed by interview with capable patients, however all assessments were 
completed by interview with the primary carer if the patient is incapable. Repeat 
measures were made after three months by an independent researcher blind as to 
allocation of treatment. For the WHOQOL Bref questions standard procedures were 
used to convert scores to a total score of quality of life (WHOQOL Group, 1995).  
 
For the Carer Uplift/Burden scale 6 questions were used to compute the total score for 
‘uplift’, each question in this scale had scores ranging from 1 to 3, where 1 indicates a 
poor rating ‘not at all’, 2 ‘some of the time’, and 3 a better rating ‘most of the time’. 
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The Carer Uplift/Burden scale has 17 questions used to compute the total score for 
‘burden’, the burden scale questions were negatively reversed and ranged from 3 to 1, 
with the poor rating of 3 ‘often’, 2 ‘sometimes and 1 the better rating of ‘never’ 
(Pruchno, 1990). Statistical analysis used the intention to treat principle and used 
analysis of covariance and variance with the STATA package.  
 
Results 
Main Findings [Figure 1 and Table 1 near here] 
Thirty patients were recruited to the trial over a period of 25 months. Fifteen (50%) 
came from two centres (B and C) with the remaining 15 (50%) coming from centre A. 
Thirteen patients were male and seventeen were female. The mean age of patients was 
40.53 and the range 46 (20-66). Fourteen patients lived in 24 hour staffed community 
homes, seven in <24 hour staffed or un-staffed community homes and the remaining 
nine patients lived with family in owner occupied or rented housing from local 
authority. Twenty-one patients were of white (English, Scottish or Welsh) ethnicity   
and nine patients included other white, Black Caribbean, Indian and Pakistani 
ethnicity. All of the 30 patients were followed up after three months successfully. The 
flow diagram (Figure 1) and clinical characteristics (table 1) of the two groups 
followed recommended procedure for randomised trials (Altman et al. 2001).  
 
In the analysis of results for the 30 randomised patients who completed all stages of 
treatment mean scores for total GAF ‘symptomatology’ and ‘social function’, 
WHOQOL-Bref (QOL) social, physical, environmental and psychological, carer uplift 
and burden, showed no difference in outcome (table 2).  
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Using two way analysis of variance in which differences in outcome were measured 
by time/treatment model interaction there was no significant difference in gains for 
clinical symptomatology (p=0.80) and social functioning (p=0.79) between assertive 
and standard groups, nor were there any significant differences in reduction of burden 
(p=0.84) to primary carers, uplift (p=0.84) of primary carers, or improvement in 
quality of life (p=0.18). The WHOQOL-Bref physical subscale (P=0.05) and 
psychological subscale (P=0.06) were not major outcomes but showed differences 
between the groups that favoured standard care.  
 
Fidelity to Assertive Treatment Model 
The number of contacts and duration of time of the clinical professionals, psychiatrist, 
psychologist/counsellor, and community nurse and outreach team illustrate the fidelity 
to the treatment models for assertive community treatment and standard community 
treatment in table 3. Table 3 shows a significant difference between the two treatment 
groups for the number of psychologist/counselling contacts and the total number of 
contacts for all professionals. However, it is important to note that while thirteen out 
of fifteen (87%) of the assertive treatment group were treated assertively, five out of 
fifteen (33%) of the standard treatment group were also treated assertively in relation 
to the fidelity treatment model (i.e. more than 12 health professional contacts over the 
3-month intervention period). Thus, there was a significant degree of overlap in the 
fidelity of the treatment groups for the number of contacts and duration of time.  
 
Discussion 
This study has demonstrated that 30 patients have statistically shown no difference 
between the two treatment groups of ‘assertive community treatment’ and ‘standard 
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community treatment’. In a heterogeneous sample of 30 patients with varied mental 
health diagnosis and behaviour problems it could still be possible that there were 
significant differences between the two treatment groups. However, the small 
differences demonstrated between the treatment groups make a Type II error unlikely, 
as such an error is normally associated with a moderate but non-significant difference 
that would become significant with larger numbers. In fact, the differences that were 
found favoured standard rather than assertive treatment and it could be argued that if a 
Type II error was present standard treatment would be the beneficiary of any doubt.  
 
The overlap between the two complex interventions was substantial and the lack of 
difference in outcome could be explained as much by lack of fidelity to the assertive 
model as by a genuine equivalence of the treatments.  The GAF can be criticised as a 
primary outcome in view of concerns about its assessment (Oliver et al, 2003) but its 
reliability is better in general psychiatric patients in a clinical setting, situations which 
were representative of the TACTILD study patients with serious mental health 
problems (Oliver et al. 2003, Loevdahl & Friis 1996, Rey et al 1995, Jones et al 
1995).  
 
With the difficulties that Oliver et al. 2002 encountered, TACTILD became a pilot 
study that was as much concerned with establishing the feasibility of randomised 
controlled trial methodology within the ID services, as with measuring the 
effectiveness of the two types of intervention.  McGrew et al. (1994) showed that 
response to ACT correlated with programme fidelity in a mental health program 
model, but this may not be a satisfactory way forward for ACT in intellectual 
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disability. Under these circumstances it is justifiable to use a pragmatic definition for 
ACT as in the TACTILD study.  
 
Published literature, particularly from outside the UK has highlighted the superiority 
of assertive community treatment models over standard care (Burns & Santos 1997; 
Drake & Burns 1995). It is fair to assume that this superiority would depend, quite 
substantially, on the quality of the standard care itself. The three centres from where 
patients were recruited for this trial have had a long ethos of multi-disciplinary 
working, well established CTLDs and intellectual disability registers, good 
accessibility to professionals and a tradition of following evidence based practice 
methods (McGrother et al. 2002; Fernando et al. 1997; Cooray & Tolmac, 1998). It is 
therefore quite possible that within these teams, professionals are working 'assertively' 
whether or not they visit patients once or more than once per week. Thus, the 
difference between the two approaches may be more apparent than real in these 
settings.  
 
What appears to be crucial is the presence of a well established and motivated 
community team rather than the particular label,  'assertive' or 'standard'. Perhaps the 
only way to establish the need or otherwise of assertive community treatment in 
intellectual disability would be to repeat this study in centres which do not have 
separate well established CLDTs; centres where service provision for this group is “ad 
hoc’ and dependent on goodwill and personal commitment of professionals” (Bouras 
et al. 2000, p.215) and to combine formal qualitative and quantitative methodology in 
evaluation (Crawford et al, 2002). As this study has shown, simple randomisation can 
be achieved ethically and safely in this population and there is no reason why such 
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studies should not be replicated in the future. Despite possible limitations in the 
choice of primary outcome measure (Oliver et al, 2003) and absence of any measures 
that might improve care (e.g. adherence to medication) we feel that this study was an 
accurate and valid attempt to record the effects of a difficult complex intervention in 
intellectual disability and hope it will stimulate other studies with larger numbers.  
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Figure 1. Flow Diagram of a trial of assertive community treatment in 
intellectual disability 
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Table 1 – Clinical Characteristics of Patients 
 Type of Community Intervention 
 Assertive Community 
Treatment (%) 
Standard Community 
Treatment (%) 
Total 
Total Sample 15 (50) 15 (50) 30 
Study Centre    
Centre A 7 (47) 8 (53) 15  
Centre B 3 (20)  3 (20) 6 
Centre C 5 (33) 4 (27) 9 
DSM IV Axis 1 Mental Disorders 
(Using ICD 10 Codes) 
   
Organic Including Symptomatic Mental 
Disorders 
0 (0) 2 (13) 2 
Schizophrenia, Schizotypal and Delusional 
Disorder 
5 (33) 3 (20) 8 
Mood Affective Disorder 3 (20) 2 (13) 5 
Neurotic, Stress-related and Somatoform 
Disorders 
2 (13) 1 (7) 3 
Behavioural Syndromes 0 (0) 2 (13) 2 
Disorders of Psychological Development 1 (7) 1 (7) 2 
Behavioural and Emotional Disorders from 
Childhood 
1 (7) 1 (7) 2 
Not Applicable (Intellectual Disability 
Only) 
3 (20) 3 (20) 6 
DSM IV Axis 2 (A) Intellectual 
Disability (Using ICD 10 Codes) 
   
Mild Intellectual Disability 12 (80) 11 (73) 23 
Moderate Intellectual Disability 3 (20) 4 (27) 7 
DSM IV Axis 2 (B) Personality 
Disorders (Using ICD 10 Codes) 
   
Specific Personality Disorders 3 (20) 1 (7) 4 
Mixed and Other Personality Disorders 0 (0) 1 (7) 1 
Not Applicable 12 (80) 13 (86) 25 
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Table 2 – Mean ratings for total GAF symptomatology and social function and 
performance, WHOQOL-Bref social, physical, environmental and psychological, 
carer uplift and burden in patients allocated to assertive community treatment 
(ACT) and standard community treatment (SCT) 
  Assessment Period 
Mean Ratios 
[Standard Deviation] 
(Range) 
Rating 
  
Community  
Intervention 
No. of 
Patients 
 
Baseline 
(0) 
Follow-up 
(3 months) 
F ratio & 
degrees of 
freedom 
 
P Value 
GAF       
Symptomatology* ACT 15 39.87 
[15.30] 
(20 - 71) 
69.07 
[8.40] 
(55 – 90) 
 SCT 15 40.13 
[14.64] 
(15 – 61) 
69.80 
[10.90] 
(40 – 85) 
    F = 0.07; 
       df= 1 
P = 0.80 
ns 
Social Function and 
Performance* 
ACT 15 41.33 
[10.99] 
(30 – 60) 
69.40 
[10.47] 
(50 – 90) 
 SCT 15 41.20 
[12.42] 
(21 - 60) 
70.33 
[10.70] 
(50 – 85) 
    F = 0.07; 
       df= 1 
P = 0.79 
ns 
WHOQOL –Bref       
Physical* ACT 15 67.14 
[12.09] 
(46 – 86) 
60.00 
[13.58] 
(32 – 82) 
 SCT 15 56.43 
[13.97] 
(29 – 82) 
65.24 
[17.10] 
(36 – 96) 
F = 3.88; 
df=1  
P = 0.05 
ns 
Psychological*  ACT 15 55.28 
[18.59] 
(21 – 92) 
57.22 
[16.48] 
(25 – 79) 
 SCT 15 45.00 
[18.64] 
(8 – 67) 
64.44 
[18.36] 
(25 – 88) 
F = 3.63; 
df = 1 
P = 0.06 
ns 
Social*  ACT 15 53.33 
[17.76] 
(25 – 83) 
63.33 
[20.19] 
(25 – 100) 
 SCT 15 49.44 
[26.81] 
(8 – 100) 
55.56 
[16.86] 
(25 – 75) 
F = 0.13;  
 df = 1 
P = 0.72 
ns 
Environmental* ACT 15 67.71 
[12.03] 
(53 – 88) 
66.46 
[16.64] 
(34 – 94) 
 SCT 15 61.67 
[11.48] 
(34 – 78) 
67.92 
[15.65] 
(38 – 91) 
F = 0.43; 
df= 1 
P = 0.51 
ns 
Carer Uplift/Burden       
Uplift* ACT 15 14.93 
[1.91] 
(11 – 18) 
15.53 
[2.45] 
(9 – 18) 
 SCT 15 13.93 
[2.05] 
(11 – 18) 
14.20 
[2.43] 
(9 – 18) 
F = 0.04;  
df=1 
P = 0.84 
ns 
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Burden # ACT 15 26.33 
[3.68] 
(22 – 35) 
25.80 
[5.19] 
(19 – 35) 
 SCT 15 32.40 
[6.22] 
(22 – 44) 
30.00 
[8.65] 
(17 – 44) 
F = 0.04; 
 df =1 
P = 0.84 
ns 
* For all these ratings a higher score indicates improvement.  
# For this rating a lower score indicates improvement. 
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Table 3 – Mean number of professional contacts and duration of time (minutes) 
in assertive community treatment (ACT) and standard community treatment 
(SCT) groups.  
 
Number of 
Contacts 
Standard 
Community 
treatment 
(SCT) 
Psychiatrist Psychologist 
and Counsellor 
Community 
Intellectual 
Disability Nurse 
Outreach 
Team 
Total 
 Mean  2.00 2.00 7.79 6.50 9.87 
 Min 1 1 1 1 1 
 
Range 
Max 4 4 18 12 25 
 Assertive 
Community 
treatment 
(ACT) 
     
 Mean  2.64 7.75 12.57 16 16.80 
 Min 1 1 2 16 2 
 
Range 
Max 8 12 40 16 41 
P-value  t = 0.66;  
df = 16 
P = 0.52, 
 ns 
t = 2.88;  
df = 8 
P = 0.02,  
significant 
t = 1.67;  
df = 26 
P = 0.11,  
ns 
t = 0.99;  
df =  1 
P = 0.50 
ns 
t = 2.25; 
df = 28 
P = 0.03,  
significant 
Duration of 
Time 
(Minutes) 
Standard 
Community 
treatment 
(SCT) 
     
 Mean  112.86 82.50 340.71  367.50 452.67 
 Min 30 30 30 15 30 
 
Range 
Max 360 135 1440 720 1800 
 Assertive 
Community 
treatment 
(ACT) 
     
 Mean  82.73 390 388.57 4860 851.33 
Min 30 60 80 4860 80  Range 
Max 240 720 1200 4860 5010 
P-value  T = -0.69; 
df = 16 
P = 0.51,  
ns 
t = 2.19; 
df = 3.09 
P = 0.11, 
 ns 
t = 0.37;  
df= 26 
P = 0.72, 
ns 
t = 7.36;  
df =1 
P = 0.09 
ns 
t = 1.18;  
df = 28 
P = 0.25 
ns 
 
